Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll…
(Reuters) - About one in eight adults have taken a drug belonging to the GLP-1 class of…
N2:DK
US FDA approves Novo Nordisk’s Wegovy for lowering heart risks
By Patrick Wingrove and Sriparna Roy (Reuters) -The U.S. Food and Drug Administration…
Novo kidney trial finds Ozempic cuts cardiac deaths in diabetics
By Stine Jacobsen and Maggie Fick COPENHAGEN (Reuters) - Novo Nordisk's widely used…
Stock pickers power up battered renewables as rates fall
By Danilo Masoni MILAN (Reuters) - Clean energy stocks might be in for a much-needed…
Red Sea shipping workarounds add costs, delays for suppliers,…
By Lisa Baertlein LOS ANGELES (Reuters) -Toymaker Basic Fun's team that oversees…
Shipping giant Maersk prepares to resume operations in Red Sea
WASHINGTON (Reuters) - Denmark's Maersk is preparing to resume shipping operations…
US offshore wind poised for success next year after turbulent 2023
By Scott DiSavino NEW YORK (Reuters) - The U.S. offshore wind industry is eying a…
US launches Red Sea force as ships reroute to avoid attacks
By Phil Stewart and John Davison MANAMA/DUBAI (Reuters) - The United States on Tuesday…
Western miners seek premium pricing for rare earth metals to break…
By Divya Rajagopal TORONTO (Reuters) - A handful of Canadian, German and Australian…